SYMAP信迈医疗
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China 2024-08-12 13:55
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert 2023-11-10 16:46
EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden 2023-05-19 14:54
SyMap Targets Renal Denervation With a Unique Map-and-Ablate Technology 2022-03-16 21:00
SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension 2022-02-23 21:00
SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical 2021-12-29 20:30
SyMap Medical Ltd. Closes Largest Financing Round in Renal Denervation Field 2021-12-07 20:30
1